Xing W - Search Results

1

The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma.

Lai R, Peng Z, Chen D, Wang X, Xing W, Zeng W, Chen M. Lai R, et al. Among authors: xing w. Anesth Analg. 2012 Feb;114(2):290-6. doi: 10.1213/ANE.0b013e318239c2e3. Epub 2011 Nov 21. Anesth Analg. 2012. PMID: 22104077

2

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W. Chen D, et al. Among authors: xing w. Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17. Ann Surg Oncol. 2012. PMID: 22588469

3

Impact of preoperative anemia on relapse and survival in breast cancer patients.

Zhang Y, Chen Y, Chen D, Jiang Y, Huang W, Ouyang H, Xing W, Zeng M, Xie X, Zeng W. Zhang Y, et al. Among authors: xing w. BMC Cancer. 2014 Nov 18;14:844. doi: 10.1186/1471-2407-14-844. BMC Cancer. 2014. PMID: 25406979 Free PMC article.

4

Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo.

Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, Xue RF, Yuan YF, Zeng WA. Xing W, et al. Anesthesiology. 2017 May;126(5):868-881. doi: 10.1097/ALN.0000000000001528. Anesthesiology. 2017. PMID: 28121635

5

Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.

Chen D, Chen Y, Yan Y, Pan J, Xing W, Li Q, Zeng W. Chen D, et al. Among authors: xing w. BMC Cancer. 2017 Aug 18;17(1):553. doi: 10.1186/s12885-017-3541-9. BMC Cancer. 2017. PMID: 28821282 Free PMC article.

6

In Reply.

Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, Xue RF, Yuan YF, Zeng WA. Xing W, et al. Anesthesiology. 2018 Feb;128(2):423. doi: 10.1097/ALN.0000000000002005. Anesthesiology. 2018. PMID: 29337754 No abstract available.

7

Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2.

Xing W, Huang P, Lu Y, Zeng W, Zuo Z. Xing W, et al. J Mol Med (Berl). 2018 May;96(5):391-402. doi: 10.1007/s00109-018-1631-z. Epub 2018 Mar 3. J Mol Med (Berl). 2018. PMID: 29502203 Free PMC article.

8

The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.

Chen DT, Pan JH, Chen YH, Xing W, Yan Y, Yuan YF, Zeng WA. Chen DT, et al. Among authors: xing w. Br J Anaesth. 2019 Jun;122(6):e157-e167. doi: 10.1016/j.bja.2018.09.030. Epub 2018 Dec 12. Br J Anaesth. 2019. PMID: 30915986 Free article.

9

JTC-801 alleviates mechanical allodynia in paclitaxel-induced neuropathic pain through the PI3K/Akt pathway.

Huang J, Chen D, Yan F, Wu S, Kang S, Xing W, Zeng W, Xie J. Huang J, et al. Among authors: xing w. Eur J Pharmacol. 2020 Sep 15;883:173306. doi: 10.1016/j.ejphar.2020.173306. Epub 2020 Jun 27. Eur J Pharmacol. 2020. PMID: 32603693

10

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.

Qi Z, Yan F, Chen D, Xing W, Li Q, Zeng W, Bi B, Xie J. Qi Z, et al. Among authors: xing w. Biosci Rep. 2020 Oct 30;40(10):BSR20202603. doi: 10.1042/BSR20202603. Biosci Rep. 2020. PMID: 33006365 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,354 results

Search Page

Filters